Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
Abstract Aim This systematic review and frequentist network meta‐analysis used random‐effects models is conducted to determine whether there are differences in the efficacy, acceptability, tolerability, and safety profiles of brexpiprazole (BRE) and aripiprazole (ARI) for Japanese with major depress...
Saved in:
Main Authors: | Taro Kishi (Author), Kenji Sakuma (Author), Takeo Saito (Author), Atsuo Nakagawa (Author), Masaki Kato (Author), Nakao Iwata (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis
by: Taro Kishi, et al.
Published: (2024) -
Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta‐analysis
by: Taro Kishi, et al.
Published: (2024) -
Lurasidone, olanzapine, and quetiapine extended‐release for bipolar depression: A systematic review and network meta‐analysis of phase 3 trials in Japan
by: Taro Kishi, et al.
Published: (2020) -
Body composition in Japanese patients with psychiatric disorders: A cross‐sectional study
by: Taro Kishi, et al.
Published: (2021) -
Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole
by: Tetsuro Kikuchi, et al.
Published: (2021)